Tirzepatide (Zepbound/Mounjaro): What Actually Happens After You Inject

This episode follows a single dose of tirzepatide—the drug sold as Zepbound and Mounjaro—from the fat under your skin into the bloodstream and through the weeks it spends reshaping hunger and blood sugar. We translate the pharmacology into plain language: how the shot absorbs over a day or two, why a fatty-acid tag gives it a five-day half-life that allows once-weekly dosing, and what 'dual agonist' actually means compared to semaglutide. Then we go organ by organ—pancreas, brain, stomach, and fat tissue—to explain why dangerous low blood sugar is rare, why food noise fades within a week, and why nausea spikes right after each dose bump. We finish with the questions people actually live with: the 2.5-to-15 mg dose ladder, why weight loss plateaus around 12 to 18 months, and what the science says happens when you stop. Produced by Fable LLM from Anthropic after intensive research current to July 2026, it's investigative and rigorous but built so anyone without a science background can follow every step. If you want honest, science-first breakdowns of the drugs shaping modern health, subscribe and follow the show. Chapters: 0:00 Intro 0:05 The Droplet That Stays for Weeks 2:43 From Belly Fat to Bloodstream 5:20 The Tide Coming In 7:36 The Paradox and the Pancreas 10:16 Quieting the Food Noise 12:38 The Slowed Stomach and the GIP Riddle 15:30 Plateau and Stopping Sources: Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide - PMC: https://pmc.ncbi.nlm.nih.gov/articles... Zepbound Pharmacokinetics (ADME): How Tirzepatide Is Absorbed, Distributed, Metabolized, and Excreted | HealthRX.com: https://healthrx.com/zepbound/pharmac... Pharos : Ligand Details - tirzepatide: https://pharos.nih.gov/ligands/tirzep... Tirzepatide Half-Life and Pharmacokinetics | Peptides Research Hub: https://peptidesresearchhub.com/resea... The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets | Nature Metabolism: https://www.nature.com/articles/s4225... Tirzepatide Bioavailability — Absorption & Dosing Science: https://www.realpeptides.co/tirzepati... Tirzepatide Pharmacokinetics — Absorption Through Clearance: https://www.realpeptides.co/tirzepati... Management of Hypoglycemia Using Continuous Glucose Monitoring During Tirzepatide Initiation or Uptitration When Used in Addition to Other Glucose-Lowering Agents - PMC: https://pmc.ncbi.nlm.nih.gov/articles... Mounjaro Pharmacokinetics: How Tirzepatide Is Absorbed, Distributed, Metabolized, and Eliminated | HealthRX.com: https://healthrx.com/mounjaro/pharmac... Tirzepatide Complete Guide: Mechanism, Research & Clinical Data | Mytide Lab: https://mytidelab.com/news/tirzepatid... Tirzepatide Dosing Guide 2026: Mounjaro & Zepbound Protocol, Half-Life & Data | PeptideDeck: https://www.peptidedeck.com/blog/tirz... Tirzepatide Half-Life and Weekly Dosing: The Pharmacokinetics Explained — Peptides Info | Peptides Info: https://peptidesinfo.health/blog/tirz... Dual GIP/GLP-1 receptor agonist tirzepatide ameliorates hepatic steatosis and inflammatory responses in a MASLD mouse model associated with the CCL2/CCR2 axis | BMC Gastroenterology | Springer Nature Link: https://link.springer.com/article/10.... Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats | Hypertension Research: https://www.nature.com/articles/s4144... Insights into the Mechanism of Action of Tirzepatide: A Narrative Review | Diabetes Therapy | Springer Nature Link: https://link.springer.com/article/10.... Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice | Scientific Reports: https://www.nature.com/articles/s4159... CME INDIA on X: "🚨 CME INDIA VERIFIED PRACTICAL GUIDE: INJ. TIRZEPATIDE (Dual GIP–GLP-1RA) 🔬 “Tirzepatide is not just weight loss—it is cardiometabolic remodeling; protect muscle, personalize dose, and monitor aggressively.” ⚙️ Mechanism: https://x.com/CMEINDIA1/status/203702... NEJM on X: "𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have pro: https://x.com/NEJM/status/20405047727... Mike Hart, M.D on X: "Ozempic = 100% appetite suppressant (GLP-1) Tirzepatide ≈ 20% appetite suppressant (GLP-1) + 80% GIP (insulin sensitvity) Retatrutide ≈ 20% appetite supressant (GLP-1) + 70% GIP (insulin sensitivy) + 10% Glucagon (calo: https://x.com/drmikehart/status/20623...